ZYUS Life Sciences Corporation announced that Wayne Brownlee, former Vice-President and Chief Financial Officer (CFO) of both Potash Corporation of Saskatchewan Inc. (PotashCorp) and Nutrien Ltd. (Nutrien), has agreed to accept an appointment to ZYUS Board of Directors. Mr. Brownlee brings a wealth of knowledge, experience and expertise to his new role with ZYUS. After acquiring a Bachelor of Science and a Master of Business Administration from the University of Saskatchewan, Mr. Brownlee began his career with the government of Saskatchewan which formed the basis for his extensive knowledge in public policy.

In 1989, Mr. Brownlee joined PotashCorp when it was a Crown corporation and was a catalyst for the expansion and development throughout its acquisition activity. He was instrumental in coordinating PotashCorps privatization, transforming the company from a provincial Crown corporation to a publicly traded company. In 2018, PotashCorp and Agrium Inc. merged to become Nutrien, the worlds largest provider of crop inputs.

Mr. Brownlee remained CFO at Nutrien until his retirement in 2018, during such time he was responsible for overseeing finance functions and playing an integral role in the multi-billion-dollar divestment of equity interests in the Chilean potash producer SQM, Israel-based ICL Group, and Jordans Arab Potash Company. Mr. Brownlee resides in Saskatoon, Saskatchewan and is a well-respected member of his community, where he devotes much of his time volunteering with various charitable organizations and serving on several other boards of directors. Mr. Brownlee is also the recipient of the University of Saskatchewan Lifetime Achievement award and the Saskatchewan Order of Merit.

The appointment of Mr. Brownlee as a director of the Company is subject to the satisfaction of certain conditions, including receipt of all applicable regulatory approvals, including that of the TSX Venture Exchange (the Exchange) and successful receipt of required security clearance from Health Canada pursuant to the Cannabis Act (Canada). Mr. Brownlee will join the Companys existing Board members, which include ZYUS Board Chair, Richard Hoyt, Vice President of Business Development at Xeris Pharmaceuticals and Managing Partner of Ozark Transaction Advisors LLC; ZYUS President and Chief Executive Officer, Brent Zettl; John Knowles, Chartered Professional Accountant with over 30 years of board and executive experience in Canadian and international companies; Garnette Weber, Co-Founder and the Chief Executive Officer of Interactive Tracking Systems Inc. since 1996; Dr. Charlotte Weber, MD, FRCPC, FAAP, faculty paediatrician in the Division of Paediatric Medicine at the Hospital for Sick Children and an Associate Professor of Paediatrics in the Department of Paediatrics at the University of Toronto Faculty of Medicine.